Review of Dose-intense Platinum and/or Paclitaxel Containing Chemotherapy in Advanced and Recurrent Epithelial Ovarian Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|25|3741-3753

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.25, 2012-07, pp. : 3741-3753

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dose-dense, dose-intense chemotherapy delivers

By  

Inpharma, Vol. 1, Iss. 1571, 2007-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

PHARMACOLOGIC STUDY OF 3-HOUR 135 mg m-2 PACLITAXEL IN PLATINUM PRETREATED PATIENTS WITH ADVANCED OVARIAN CANCER

By Panday V.R.N.A.N.N.A.N.   Huizing M.T.   van WARMERDAM L.J.C.   Dubbelman R.C.   Mandjes I.   Schellens J.H.M.   Huinink W.W.T.E.N.B.O.K.K.E.L.   Beijnen J.H.  

Pharmacological Research, Vol. 38, Iss. 3, 1998-01 ,pp. : 231-236

Academic Press

Access to resources Recommend Favorite

Management Strategies for Recurrent Platinum-Resistant Ovarian Cancer

By Naumann R. Wendel  

Drugs, Vol. 71, Iss. 11, 2011-07 ,pp. : 1397-1412

Adis International

Access to resources Recommend Favorite

Rational Use of Cytotoxic Chemotherapy for Recurrent Ovarian Cancer

By Liu Joyce   Matulonis Ursula  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 9, 2006-10 ,pp. : 947-953

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Chemotherapy for Advanced, Recurrent, and Metastatic Cervical Cancer

By Moore David H.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 1, 2008-01 ,pp. : 53-57

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite